Abbott Laboratories
ABT
$109.54
$0.920.84%
NYSE
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 5.43B | 6.28B | 6.52B | 13.98B | 13.98B |
| Total Depreciation and Amortization | 3.45B | 3.16B | 3.12B | 3.13B | 3.14B |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 783.00M | 757.00M | 729.00M | 1.14B | 1.14B |
| Change in Net Operating Assets | 251.00M | -732.00M | -803.00M | -9.13B | -9.22B |
| Cash from Operations | 9.91B | 9.46B | 9.57B | 9.12B | 9.04B |
| Capital Expenditure | -2.08B | -2.09B | -2.17B | -2.20B | -2.26B |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -20.04B | -19.90B | -105.00M | -85.00M | -30.00M |
| Divestitures | -- | -- | -- | 0.00 | 0.00 |
| Other Investing Activities | -249.00M | -287.00M | -146.00M | -88.00M | -220.00M |
| Cash from Investing | -22.37B | -22.28B | -2.42B | -2.38B | -2.51B |
| Total Debt Issued | 19.92B | 19.90B | 5.00M | 4.00M | 5.00M |
| Total Debt Repaid | -3.39B | -2.00B | -1.62B | -2.16B | -1.63B |
| Issuance of Common Stock | 193.00M | 225.00M | 396.00M | 416.00M | 439.00M |
| Repurchase of Common Stock | -1.83B | -793.00M | -893.00M | -906.00M | -1.35B |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -4.26B | -4.19B | -4.12B | -4.04B | -3.97B |
| Other Financing Activities | 0.00 | -82.00M | -82.00M | -82.00M | -82.00M |
| Cash from Financing | 10.64B | 13.06B | -6.31B | -6.77B | -6.59B |
| Foreign Exchange rate Adjustments | -23.00M | 24.00M | 71.00M | -18.00M | 28.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.85B | 271.00M | 906.00M | -47.00M | -36.00M |